Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-year bone marrow study of eltrombopag in previously treated adults with chronic immune thrombocytopenic purpura
2009-010421-39Phase 4Completed
- Sponsor
- GSK
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of eltrombopag in immune thrombocytopenic purpura (ITP), sponsored by GSK. Started Feb 2010; status: completed.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenic purpura (ITP)
Beyond the preview
Go deeper on 2009-010421-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010421-39.